References
Reinhart K, Perner A, Sprung CL, Jaeschke R, Schortgen F, Johan Groeneveld AB, Beale R, Hartog CS (2012) Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients. Intensive Care Med 38:368–383. doi:10.1007/s00134-012-2472-9
Woessner R, Grauer MT, Dieterich HJ, Bepperling F, Baus D, Kahles T, Georgi S, Bianchi O, Morgenthaler M, Treib J (2003) Influence of a long-term, high-dose volume therapy with 6 % hydroxyethyl starch 130/0.4 or crystalloid solution on hemodynamics, rheology and hemostasis in patients with acute ischemic stroke. Results of a randomized, placebo-controlled, double-blind study. Pathophysiol Haemost Thromb 33:121–126
Rudolf J (2002) Hydroxyethyl starch for hypervolemic hemodilution in patients with acute ischemic stroke: a randomized, placebo-controlled phase II safety study. Cerebrovasc Dis 14:33–41
Bruder N, Rabinstein A (2011) Cardiovascular and pulmonary complications of aneurysmal subarachnoid hemorrhage. Neurocrit Care 15:257–269
Mutoh T, Kazumata K, Ishikawa T, Terasaka S (2009) Performance of bedside transpulmonary thermodilution monitoring for goal-directed hemodynamic management after subarachnoid hemorrhage. Stroke 40:2368–2374
Conflicts of interest
None of the authors have any financial relationship with a commercial interest to disclose.
Author information
Authors and Affiliations
Corresponding author
Additional information
An author’s reply to this comment is available at: doi: 10.1007/s00134-012-2642-9.
On behalf of the French-speaking Neurocritical Care Society.
Rights and permissions
About this article
Cite this article
Payen, JF., Vigue, B., Audibert, G. et al. Should we ban the use of colloids in patients with head injury?. Intensive Care Med 38, 1561–1562 (2012). https://doi.org/10.1007/s00134-012-2640-y
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-012-2640-y